Jiarui Ding
Jiarui Ding
Postdoc, Broad Institute of MIT and Harvard
Verified email at mit.edu
Cited by
Cited by
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...
Nature 486 (7403), 395-399, 2012
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ...
The Journal of pathology 231 (1), 21-34, 2013
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ...
Blood 122 (7), 1256-1265, 2013
Use of mutation profiles to refine the classification of endometrial carcinomas
MK McConechy, J Ding, MCU Cheang, KC Wiegand, J Senz, AA Tone, ...
The Journal of pathology 228 (1), 20-30, 2012
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data
G Ha, A Roth, J Khattra, J Ho, D Yap, LM Prentice, N Melnyk, ...
Genome research 24 (11), 1881-1893, 2014
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer
G Ha, A Roth, D Lai, A Bashashati, J Ding, R Goya, R Giuliany, J Rosner, ...
Genome research 22 (10), 1995-2007, 2012
JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data
A Roth, J Ding, R Morin, A Crisan, G Ha, R Giuliany, A Bashashati, M Hirst, ...
Bioinformatics 28 (7), 907-913, 2012
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
MK McConechy, J Ding, J Senz, W Yang, N Melnyk, AA Tone, LM Prentice, ...
Modern Pathology 27 (1), 128-134, 2014
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer
A Bashashati, G Haffari, J Ding, G Ha, K Lui, J Rosner, DG Huntsman, ...
Genome biology 13 (12), R124, 2012
Feature-based classifiers for somatic mutation detection in tumour–normal paired sequencing data
J Ding, A Bashashati, A Roth, A Oloumi, K Tse, T Zeng, G Haffari, M Hirst, ...
Bioinformatics 28 (2), 167-175, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
JN McAlpine, H Porter, M Köbel, BH Nelson, LM Prentice, SE Kalloger, ...
Modern Pathology 25 (5), 740-750, 2012
Interpretable dimensionality reduction of single cell transcriptome data with deep generative models
J Ding, A Condon, SP Shah
Nature communications 9 (1), 1-13, 2018
Systematic comparison of single-cell and single-nucleus RNA-sequencing methods
J Ding, X Adiconis, SK Simmons, MS Kowalczyk, CC Hession, ...
Nature biotechnology, 1-10, 2020
Systematic analysis of somatic mutations impacting gene expression in 12 tumour types
J Ding, MK McConechy, HM Horlings, G Ha, FC Chan, T Funnell, ...
Nature communications 6 (1), 1-13, 2015
Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas
A Mathelier, C Lefebvre, AW Zhang, DJ Arenillas, J Ding, WW Wasserman, ...
Genome biology 16 (1), 84, 2015
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
PL Clermont, F Crea, YT Chiang, D Lin, A Zhang, JZL Wang, A Parolia, ...
Clinical epigenetics 8 (1), 1-14, 2016
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
AA Tone, MK McConechy, W Yang, J Ding, S Yip, E Kong, KK Wong, ...
BMC cancer 14 (1), 1-13, 2014
Transcriptional atlas of intestinal immune cells reveals that neuropeptide α-CGRP modulates group 2 innate lymphoid cell responses
H Xu, J Ding, CBM Porter, A Wallrapp, M Tabaka, S Ma, S Fu, X Guo, ...
Immunity 51 (4), 696-708. e9, 2019
SVM-RFE based feature selection for tandem mass spectrum quality assessment
J Ding, J Shi, FX Wu
International journal of data mining and bioinformatics 5 (1), 73-88, 2011
An RCOR1 loss–associated gene expression signature identifies a prognostically significant DLBCL subgroup
FC Chan, A Telenius, S Healy, S Ben-Neriah, A Mottok, R Lim, M Drake, ...
Blood, The Journal of the American Society of Hematology 125 (6), 959-966, 2015
The system can't perform the operation now. Try again later.
Articles 1–20